IntraLase IPO raises $87M for future growth

California governor vetoes bill that would have reduced licensing requirements to perfom eye surgery

Visus Therapeutics expands ophthalmic drug development portfolio with acquisition of ViewPoint Therapeutics' assets

The survey, from The Larry A. Greene Center and the Primary Care Collaborative, found that the COVID-19 pandemic has had an adverse impact on the well-being of physicians.